LGND

Nasdaq

LIGAND PHARMACEUTICALS INC

Latest disclosureOctober 6, 2026

Insider score Why 0?: 0/ 100
Qualifying buys · 30d: $0

0 purchases · 74 sales

Price by TradingView

Insider transactions 139

Limited filing history

Filters

Last 30 daysNo qualifying insider buying. Sales: $3.29M by 2 insiders.

Showing the first 6 of 74 trades on this page.

Sale disclosed

Andrew Reardon

CLO & Secretary

Common Stock

Reported value: $251.99K
Reported price: $302.5107 / share

Sale disclosed

Andrew Reardon

CLO & Secretary

Common Stock

Reported value: $599.8K
Reported price: $303.5444 / share

Sale disclosed

Andrew Reardon

CLO & Secretary

Common Stock

Reported value: $467.43K
Reported price: $304.5154 / share

Sale disclosed

Andrew Reardon

CLO & Secretary

Common Stock

Reported value: $123.7K
Reported price: $306.1834 / share

Sale disclosed

Andrew Reardon

CLO & Secretary

Common Stock

Reported value: $72.19K
Reported price: $307.1911 / share

Sale disclosed

Andrew Reardon

CLO & Secretary

Common Stock

Reported value: $5.23K
Reported price: $307.74 / share

Sale disclosed

Martine Zimmermann

Director

Common Stock

Reported value: $342K
Reported price: $285.00 / share

Sale disclosed

Andrew Reardon

CLO & Secretary

Common Stock

Reported value: $85.2K
Reported price: $283.9854 / share

Sale disclosed

Andrew Reardon

CLO & Secretary

Common Stock

Reported value: $513.3K
Reported price: $285.1671 / share

Sale disclosed

Andrew Reardon

CLO & Secretary

Common Stock

Reported value: $605.65K
Reported price: $286.3589 / share

Sale disclosed

Andrew Reardon

CLO & Secretary

Common Stock

Reported value: $110.7K
Reported price: $287.5253 / share

Sale disclosed

Andrew Reardon

CLO & Secretary

Common Stock

Reported value: $115.59K
Reported price: $288.9792 / share

Sale disclosed

Octavio Espinoza

Chief Financial Officer

Common Stock

Reported value: $9.24M
Reported price: $292.065 / share

Sale disclosed

Jason Haas

Director

Common Stock

Reported value: $2.09M
Reported price: $292.8078 / share

Sale disclosed

Andrew Reardon

CLO & Secretary

Common Stock

Reported value: $29.83K
Reported price: $284.1375 / share

Sale disclosed

Andrew Reardon

CLO & Secretary

Common Stock

Reported value: $9.39K
Reported price: $284.553 / share

Sale disclosed

Andrew Reardon

CLO & Secretary

Common Stock

Reported value: $44.86K
Reported price: $285.7357 / share

Sale disclosed

Andrew Reardon

CLO & Secretary

Common Stock

Reported value: $295.97K
Reported price: $286.7968 / share

Sale disclosed

Andrew Reardon

CLO & Secretary

Common Stock

Reported value: $349.36K
Reported price: $287.7731 / share

Sale disclosed

Andrew Reardon

CLO & Secretary

Common Stock

Reported value: $102.79K
Reported price: $288.7496 / share

Sale disclosed

Andrew Reardon

CLO & Secretary

Common Stock

Reported value: $145.77K
Reported price: $289.8022 / share

Sale disclosed

Andrew Reardon

CLO & Secretary

Common Stock

Reported value: $58.12K
Reported price: $290.60 / share

Sale disclosed

Andrew Reardon

CLO & Secretary

Common Stock

Reported value: $289.09K
Reported price: $291.7119 / share

Sale disclosed

Andrew Reardon

CLO & Secretary

Common Stock

Reported value: $119.76K
Reported price: $292.8191 / share

Sale disclosed

Andrew Reardon

CLO & Secretary

Common Stock

Reported value: $122.36K
Reported price: $308.9886 / share

Sale disclosed

Andrew Reardon

CLO & Secretary

Common Stock

Reported value: $32.26K
Reported price: $310.2023 / share

Sale disclosed

Andrew Reardon

CLO & Secretary

Common Stock

Reported value: $348.81K
Reported price: $311.72 / share

Sale disclosed

Andrew Reardon

CLO & Secretary

Common Stock

Reported value: $337.57K
Reported price: $312.2784 / share

Sale disclosed

Andrew Reardon

CLO & Secretary

Common Stock

Reported value: $219.42K
Reported price: $313.4574 / share

Sale disclosed

Andrew Reardon

CLO & Secretary

Common Stock

Reported value: $31.46K
Reported price: $314.5788 / share

Sale disclosed

Andrew Reardon

CLO & Secretary

Common Stock

Reported value: $284.2K
Reported price: $315.7775 / share

Sale disclosed

Andrew Reardon

CLO & Secretary

Common Stock

Reported value: $190.29K
Reported price: $317.1517 / share

Sale disclosed

Stephen L. Sabba

Director

Common Stock

Reported value: $544.83K
Reported price: $254.00 / share

Sale disclosed

Jason Haas

Director

Common Stock

Reported value: $765.03K
Reported price: $255.0113 / share

Sale disclosed

Jason Haas

Director

Common Stock

Reported value: $886.29K
Reported price: $256.0781 / share

Sale disclosed

Jason Aryeh

Director

Common Stock

Reported value: $125K
Reported price: $250.00 / share

Sale disclosed

Jason Aryeh

Director

Common Stock

Reported value: $1.13M
Reported price: $250.00 / share

Sale disclosed

John L. Lamattina

Director

Common Stock

Reported value: $63.54K
Reported price: $247.2237 / share

Sale disclosed

John L. Lamattina

Director

Common Stock

Reported value: $57.56K
Reported price: $248.1111 / share

Sale disclosed

John L. Lamattina

Director

Common Stock

Reported value: $173.92K
Reported price: $249.5326 / share

Sale disclosed

John L. Lamattina

Director

Common Stock

Reported value: $856.75K
Reported price: $251.6158 / share

Sale disclosed

Andrew Reardon

CLO & Secretary

Common Stock

Reported value: $109.96K
Reported price: $223.9467 / share

Sale disclosed

Andrew Reardon

CLO & Secretary

Common Stock

Reported value: $152.46K
Reported price: $225.1983 / share

Sale disclosed

Andrew Reardon

CLO & Secretary

Common Stock

Reported value: $323.59K
Reported price: $225.9672 / share

Sale disclosed

Andrew Reardon

CLO & Secretary

Common Stock

Reported value: $90.71K
Reported price: $226.7794 / share

Sale disclosed

Andrew Reardon

CLO & Secretary

Common Stock

Reported value: $133.49K
Reported price: $228.5738 / share

Sale disclosed

Andrew Reardon

CLO & Secretary

Common Stock

Reported value: $279.03K
Reported price: $229.4676 / share

Sale disclosed

Andrew Reardon

CLO & Secretary

Common Stock

Reported value: $46.08K
Reported price: $230.41 / share

Sale disclosed

John W. Kozarich

Director

Common Stock

Reported value: $18.19K
Reported price: $227.3675 / share

Sale disclosed

John W. Kozarich

Director

Common Stock

Reported value: $229.87
Reported price: $229.87 / share

Sale disclosed

John W. Kozarich

Director

Common Stock

Reported value: $38.26K
Reported price: $231.8671 / share

Sale disclosed

John W. Kozarich

Director

Common Stock

Reported value: $24.42K
Reported price: $232.5704 / share

Sale disclosed

John W. Kozarich

Director

Common Stock

Reported value: $27.15K
Reported price: $234.0853 / share

Sale disclosed

John W. Kozarich

Director

Common Stock

Reported value: $102.82K
Reported price: $224.00 / share

Sale disclosed

John W. Kozarich

Director

Common Stock

Reported value: $352.01K
Reported price: $223.50 / share

Sale disclosed

Andrew Reardon

CLO & Secretary

Common Stock

Reported value: $136.47K
Reported price: $227.4493 / share

Sale disclosed

Andrew Reardon

CLO & Secretary

Common Stock

Reported value: $213.2K
Reported price: $228.7537 / share

Sale disclosed

Andrew Reardon

CLO & Secretary

Common Stock

Reported value: $22.51K
Reported price: $229.7086 / share

Sale disclosed

Andrew Reardon

CLO & Secretary

Common Stock

Reported value: $85.42K
Reported price: $230.8692 / share

Sale disclosed

Andrew Reardon

CLO & Secretary

Common Stock

Reported value: $180.99K
Reported price: $232.0399 / share

Sale disclosed

Andrew Reardon

CLO & Secretary

Common Stock

Reported value: $330.75K
Reported price: $232.922 / share

Sale disclosed

Andrew Reardon

CLO & Secretary

Common Stock

Reported value: $187.21K
Reported price: $234.0177 / share

Sale disclosed

John W. Kozarich

Director

Common Stock

Reported value: $29.2K
Reported price: $199.9749 / share

Sale disclosed

John W. Kozarich

Director

Common Stock

Reported value: $8.05K
Reported price: $201.235 / share

Sale disclosed

John W. Kozarich

Director

Common Stock

Reported value: $15.99K
Reported price: $202.4223 / share

Sale disclosed

John W. Kozarich

Director

Common Stock

Reported value: $8.73K
Reported price: $202.9122 / share

Sale disclosed

John W. Kozarich

Director

Common Stock

Reported value: $32.48K
Reported price: $204.2627 / share

Sale disclosed

Andrew Reardon

CLO & Secretary

Common Stock

Reported value: $91.47K
Reported price: $198.8493 / share

Sale disclosed

Andrew Reardon

CLO & Secretary

Common Stock

Reported value: $260.04K
Reported price: $199.7221 / share

Sale disclosed

Andrew Reardon

CLO & Secretary

Common Stock

Reported value: $248.77K
Reported price: $200.9429 / share

Sale disclosed

Andrew Reardon

CLO & Secretary

Common Stock

Reported value: $141.33K
Reported price: $201.8971 / share

Sale disclosed

Andrew Reardon

CLO & Secretary

Common Stock

Reported value: $195.7K
Reported price: $203.2218 / share

Sale disclosed

Andrew Reardon

CLO & Secretary

Common Stock

Reported value: $68.92K
Reported price: $204.5026 / share

Sale disclosed

John L. Lamattina

Director

Common Stock

Reported value: $433.84K
Reported price: $200.76 / share

Reporting insider	Security / transaction	Amount / price	Value	Traded / disclosed	Source
CLO & Secretary	Common StockSale10b5-16 trades	5,000avg $304.07 / share	$1.52M	Oct 2Filed Oct 6 · 4d later	6 filings 833 @ $302.51 · $251.99KSEC filing 1,976 @ $303.54 · $599.8KSEC filing 1,535 @ $304.52 · $467.43KSEC filing 404 @ $306.18 · $123.7KSEC filing 235 @ $307.19 · $72.19KSEC filing 17 @ $307.74 · $5.23KSEC filing
Director	Common StockSale	1,200$285.00 / share	$342K	Sep 10Filed Sep 14 · 4d later	SEC filing
CLO & Secretary	Common StockSale10b5-15 trades	5,000avg $286.09 / share	$1.43M	Sep 3Filed Sep 8 · 5d later	5 filings 300 @ $283.99 · $85.2KSEC filing 1,800 @ $285.17 · $513.3KSEC filing 2,115 @ $286.36 · $605.65KSEC filing 385 @ $287.53 · $110.7KSEC filing 400 @ $288.98 · $115.59KSEC filing
Chief Financial Officer	Common StockSale10b5-1	31,641$292.07 / share	$9.24M	Aug 12Filed Aug 14 · 2d later	SEC filing
Director	Common StockSale	7,138$292.81 / share	$2.09M	Aug 12Filed Aug 14 · 2d later	SEC filing
CLO & Secretary	Common StockSale10b5-110 trades	5,000avg $288.99 / share	$1.44M	Aug 3Filed Aug 4 · 1d later	10 filings 105 @ $284.14 · $29.83KSEC filing 33 @ $284.55 · $9.39KSEC filing 157 @ $285.74 · $44.86KSEC filing 1,032 @ $286.80 · $295.97KSEC filing 1,214 @ $287.77 · $349.36KSEC filing 356 @ $288.75 · $102.79KSEC filing 503 @ $289.80 · $145.77KSEC filing 200 @ $290.60 · $58.12KSEC filing 991 @ $291.71 · $289.09KSEC filing 409 @ $292.82 · $119.76KSEC filing
CLO & Secretary	Common StockSale10b5-18 trades	5,000avg $313.28 / share	$1.57M	Jul 1Filed Jul 6 · 5d later	8 filings 396 @ $308.99 · $122.36KSEC filing 104 @ $310.20 · $32.26KSEC filing 1,119 @ $311.72 · $348.81KSEC filing 1,081 @ $312.28 · $337.57KSEC filing 700 @ $313.46 · $219.42KSEC filing 100 @ $314.58 · $31.46KSEC filing 900 @ $315.78 · $284.2KSEC filing 600 @ $317.15 · $190.29KSEC filing
Director	Common StockSale	2,145$254.00 / share	$544.83K	Jun 16Filed Jun 18 · 2d later	SEC filing
Director	Common StockSale2 trades	6,461avg $255.58 / share	$1.65M	Jun 12Filed Jun 15 · 3d later	2 filings 3,000 @ $255.01 · $765.03KSEC filing 3,461 @ $256.08 · $886.29KSEC filing
Director	Common StockSale	500$250.00 / share	$125K	Jun 10Filed Jun 12 · 2d later	SEC filing
Director	Common StockSale	4,500$250.00 / share	$1.13M	Jun 11Filed Jun 12 · 1d later	SEC filing
Director	Common StockSale4 trades	4,591avg $250.88 / share	$1.15M	Jun 10Filed Jun 12 · 2d later	4 filings 257 @ $247.22 · $63.54KSEC filing 232 @ $248.11 · $57.56KSEC filing 697 @ $249.53 · $173.92KSEC filing 3,405 @ $251.62 · $856.75KSEC filing
CLO & Secretary	Common StockSale10b5-17 trades	5,000avg $227.06 / share	$1.14M	Jun 1Filed Jun 2 · 1d later	7 filings 491 @ $223.95 · $109.96KSEC filing 677 @ $225.20 · $152.46KSEC filing 1,432 @ $225.97 · $323.59KSEC filing 400 @ $226.78 · $90.71KSEC filing 584 @ $228.57 · $133.49KSEC filing 1,216 @ $229.47 · $279.03KSEC filing 200 @ $230.41 · $46.08KSEC filing
Director	Common StockSale10b5-15 trades	467avg $231.80 / share	$108.25K	May 1Filed May 14 · 13d later	5 filings 80 @ $227.37 · $18.19KSEC filing 1 @ $229.87 · $229.87SEC filing 165 @ $231.87 · $38.26KSEC filing 105 @ $232.57 · $24.42KSEC filing 116 @ $234.09 · $27.15KSEC filing
Director	Common StockSale10b5-1	459$224.00 / share	$102.82K	May 12Filed May 14 · 2d later	SEC filing
Director	Common StockSale10b5-1	1,575$223.50 / share	$352.01K	May 13Filed May 14 · 1d later	SEC filing
CLO & Secretary	Common StockSale10b5-17 trades	5,000avg $231.31 / share	$1.16M	May 1Filed May 4 · 3d later	7 filings 600 @ $227.45 · $136.47KSEC filing 932 @ $228.75 · $213.2KSEC filing 98 @ $229.71 · $22.51KSEC filing 370 @ $230.87 · $85.42KSEC filing 780 @ $232.04 · $180.99KSEC filing 1,420 @ $232.92 · $330.75KSEC filing 800 @ $234.02 · $187.21KSEC filing
Director	Common StockSale10b5-15 trades	467avg $202.23 / share	$94.44K	Apr 1Filed Apr 2 · 1d later	5 filings 146 @ $199.97 · $29.2KSEC filing 40 @ $201.24 · $8.05KSEC filing 79 @ $202.42 · $15.99KSEC filing 43 @ $202.91 · $8.73KSEC filing 159 @ $204.26 · $32.48KSEC filing
CLO & Secretary	Common StockSale10b5-16 trades	5,000avg $201.24 / share	$1.01M	Apr 1Filed Apr 2 · 1d later	6 filings 460 @ $198.85 · $91.47KSEC filing 1,302 @ $199.72 · $260.04KSEC filing 1,238 @ $200.94 · $248.77KSEC filing 700 @ $201.90 · $141.33KSEC filing 963 @ $203.22 · $195.7KSEC filing 337 @ $204.50 · $68.92KSEC filing
Director	Common StockSale	2,161$200.76 / share	$433.84K	Mar 6Filed Mar 31 · 25d later	SEC filing

Congress transactions 4

All Congress filings

Purchase disclosed

Ligand Pharmaceuticals Incorporated - Common Stock (LGND) · Stock

The filing reports a purchase for the member.

Gilbert CisnerosReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: May 29, 2026

Purchase disclosed

Ligand Pharmaceuticals Incorporated - Common Stock (LGND) · Stock

The filing reports a purchase for the member.

Gilbert CisnerosReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: March 3, 2026

Purchase disclosed

Ligand Pharmaceuticals Incorporated - Common Stock (LGND) · Stock

The filing reports a purchase for the member.

Gilbert CisnerosReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: January 15, 2026

Purchase disclosed

Ligand Pharmaceuticals Incorporated - Common Stock (LGND) · Stock

The filing reports a purchase for the member.

Gilbert CisnerosReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: January 5, 2026

Why this buying score?

No qualifying common-equity purchases

No eligible common-equity purchase is public by this cutoff within 180 transaction-date days. Other instruments, exercises and routine activity do not contribute purchase points.

+0 pts

This score describes qualifying insider purchases at issuer level. Read the methodology

Sources and coverage

Limited filing history · Market-wide discovery does not establish complete company history. View coverage

Source: SEC EDGAR · Form 4
Issuer CIK: 0000886163
Latest public acceptance: Oct 6, 2026, 08:35 PM UTC
Score calculated: Oct 8, 2026, 12:04 AM UTC
Parser: form4-parser-1.5
Classifier: form4-classifier-1.1
Scoring methodology: insider-experimental-1.1
Availability: Public filing time, not trade date

Open a transaction's SEC filing for the primary evidence. A code P may describe an open-market or private purchase; classification is not proof of intent.

Insider activity can have many explanations. Signal Strength is not a probability of profit or a recommendation to trade.

Reporting insider

Security / transaction

Amount / price

Value

Traded / disclosed

Source

CLO & Secretary

Common StockSale10b5-16 trades

5,000avg $304.07 / share

$1.52M

Oct 2Filed Oct 6 · 4d later

6 filings

833 @ $302.51 · $251.99KSEC filing
1,976 @ $303.54 · $599.8KSEC filing
1,535 @ $304.52 · $467.43KSEC filing
404 @ $306.18 · $123.7KSEC filing
235 @ $307.19 · $72.19KSEC filing
17 @ $307.74 · $5.23KSEC filing

Director

Common StockSale

1,200$285.00 / share

$342K

Sep 10Filed Sep 14 · 4d later

SEC filing

CLO & Secretary

Common StockSale10b5-15 trades

5,000avg $286.09 / share

$1.43M

Sep 3Filed Sep 8 · 5d later

5 filings

300 @ $283.99 · $85.2KSEC filing
1,800 @ $285.17 · $513.3KSEC filing
2,115 @ $286.36 · $605.65KSEC filing
385 @ $287.53 · $110.7KSEC filing
400 @ $288.98 · $115.59KSEC filing

Chief Financial Officer

Common StockSale10b5-1

31,641$292.07 / share

$9.24M

Aug 12Filed Aug 14 · 2d later

SEC filing

Director

Common StockSale

7,138$292.81 / share

$2.09M

Aug 12Filed Aug 14 · 2d later

SEC filing

CLO & Secretary

Common StockSale10b5-110 trades

5,000avg $288.99 / share

$1.44M

Aug 3Filed Aug 4 · 1d later

10 filings

105 @ $284.14 · $29.83KSEC filing
33 @ $284.55 · $9.39KSEC filing
157 @ $285.74 · $44.86KSEC filing
1,032 @ $286.80 · $295.97KSEC filing
1,214 @ $287.77 · $349.36KSEC filing
356 @ $288.75 · $102.79KSEC filing
503 @ $289.80 · $145.77KSEC filing
200 @ $290.60 · $58.12KSEC filing
991 @ $291.71 · $289.09KSEC filing
409 @ $292.82 · $119.76KSEC filing

CLO & Secretary

Common StockSale10b5-18 trades

5,000avg $313.28 / share

$1.57M

Jul 1Filed Jul 6 · 5d later

8 filings

396 @ $308.99 · $122.36KSEC filing
104 @ $310.20 · $32.26KSEC filing
1,119 @ $311.72 · $348.81KSEC filing
1,081 @ $312.28 · $337.57KSEC filing
700 @ $313.46 · $219.42KSEC filing
100 @ $314.58 · $31.46KSEC filing
900 @ $315.78 · $284.2KSEC filing
600 @ $317.15 · $190.29KSEC filing

Director

Common StockSale

2,145$254.00 / share

$544.83K

Jun 16Filed Jun 18 · 2d later

SEC filing

Director

Common StockSale2 trades

6,461avg $255.58 / share

$1.65M

Jun 12Filed Jun 15 · 3d later

2 filings

3,000 @ $255.01 · $765.03KSEC filing
3,461 @ $256.08 · $886.29KSEC filing

Director

Common StockSale

500$250.00 / share

$125K

Jun 10Filed Jun 12 · 2d later

SEC filing

Director

Common StockSale

4,500$250.00 / share

$1.13M

Jun 11Filed Jun 12 · 1d later

SEC filing

Director

Common StockSale4 trades

4,591avg $250.88 / share

$1.15M

Jun 10Filed Jun 12 · 2d later

4 filings

257 @ $247.22 · $63.54KSEC filing
232 @ $248.11 · $57.56KSEC filing
697 @ $249.53 · $173.92KSEC filing
3,405 @ $251.62 · $856.75KSEC filing

CLO & Secretary

Common StockSale10b5-17 trades

5,000avg $227.06 / share

$1.14M

Jun 1Filed Jun 2 · 1d later

7 filings

491 @ $223.95 · $109.96KSEC filing
677 @ $225.20 · $152.46KSEC filing
1,432 @ $225.97 · $323.59KSEC filing
400 @ $226.78 · $90.71KSEC filing
584 @ $228.57 · $133.49KSEC filing
1,216 @ $229.47 · $279.03KSEC filing
200 @ $230.41 · $46.08KSEC filing

Director

Common StockSale10b5-15 trades

467avg $231.80 / share

$108.25K

May 1Filed May 14 · 13d later

5 filings

80 @ $227.37 · $18.19KSEC filing
1 @ $229.87 · $229.87SEC filing
165 @ $231.87 · $38.26KSEC filing
105 @ $232.57 · $24.42KSEC filing
116 @ $234.09 · $27.15KSEC filing

Director

Common StockSale10b5-1

459$224.00 / share

$102.82K

May 12Filed May 14 · 2d later

SEC filing

Director

Common StockSale10b5-1

1,575$223.50 / share

$352.01K

May 13Filed May 14 · 1d later

SEC filing

CLO & Secretary

Common StockSale10b5-17 trades

5,000avg $231.31 / share

$1.16M

May 1Filed May 4 · 3d later

7 filings

600 @ $227.45 · $136.47KSEC filing
932 @ $228.75 · $213.2KSEC filing
98 @ $229.71 · $22.51KSEC filing
370 @ $230.87 · $85.42KSEC filing
780 @ $232.04 · $180.99KSEC filing
1,420 @ $232.92 · $330.75KSEC filing
800 @ $234.02 · $187.21KSEC filing

Director

Common StockSale10b5-15 trades

467avg $202.23 / share

$94.44K

Apr 1Filed Apr 2 · 1d later

5 filings

146 @ $199.97 · $29.2KSEC filing
40 @ $201.24 · $8.05KSEC filing
79 @ $202.42 · $15.99KSEC filing
43 @ $202.91 · $8.73KSEC filing
159 @ $204.26 · $32.48KSEC filing

CLO & Secretary

Common StockSale10b5-16 trades

5,000avg $201.24 / share

$1.01M

Apr 1Filed Apr 2 · 1d later

6 filings

460 @ $198.85 · $91.47KSEC filing
1,302 @ $199.72 · $260.04KSEC filing
1,238 @ $200.94 · $248.77KSEC filing
700 @ $201.90 · $141.33KSEC filing
963 @ $203.22 · $195.7KSEC filing
337 @ $204.50 · $68.92KSEC filing

Director

Common StockSale

2,161$200.76 / share

$433.84K

Mar 6Filed Mar 31 · 25d later

SEC filing

Why this buying score?

No qualifying common-equity purchases

No eligible common-equity purchase is public by this cutoff within 180 transaction-date days. Other instruments, exercises and routine activity do not contribute purchase points.

+0 pts

This score describes qualifying insider purchases at issuer level. Read the methodology

Sources and coverage

Limited filing history · Market-wide discovery does not establish complete company history. View coverage

Source: SEC EDGAR · Form 4
Issuer CIK: 0000886163
Latest public acceptance: Oct 6, 2026, 08:35 PM UTC
Score calculated: Oct 8, 2026, 12:04 AM UTC
Parser: form4-parser-1.5
Classifier: form4-classifier-1.1
Scoring methodology: insider-experimental-1.1
Availability: Public filing time, not trade date

Open a transaction's SEC filing for the primary evidence. A code P may describe an open-market or private purchase; classification is not proof of intent.